Loading...
•
Jun 29, 2024
Thermo Fisher Q2 2024 Earnings Report
Thermo Fisher Scientific reported strong financial performance and share gain in Q2 2024.
Key Takeaways
Thermo Fisher Scientific reported a revenue of $10.54 billion for the second quarter of 2024. GAAP diluted EPS increased by 15% to $4.04, and adjusted EPS increased by 4% to $5.37. The company is raising its full-year revenue and adjusted EPS guidance.
Second quarter revenue was $10.54 billion.
Second quarter GAAP diluted earnings per share (EPS) increased 15% to $4.04.
Second quarter adjusted EPS increased 4% to $5.37.
The company completed its acquisition of Olink, a provider of differentiated next-generation proteomic solutions.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
Thermo Fisher is raising its full-year revenue and adjusted EPS guidance.
Positive Outlook
- Raising revenue guidance to a new range of $42.4 to $43.3 billion versus its previous guidance of $42.3 to $43.3 billion.
- Raising adjusted EPS guidance to a new range of $21.29 to $22.07 versus its previous guidance of $21.14 to $22.02.
Revenue & Expenses
Visualization of income flow from segment revenue to net income